Exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine

Only one treatment for malignant mesothelioma has been approved since 2003 and rates of the disease are rising worldwide; thus, new treatments must be found. Here, Dean Fennell, PhD, FRCP, of Universi... Author: VJOncology Added: 02/13/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts